NVOs next-generation once-daily oral pill Amycretin, a GLP-1 and amylin receptor agonist, helped patients lose an average of 13% of their body weight after 12 weeks in an early-stage trial
JACC 65(20):21592169 Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise
Visceral fatthe metabolically active adipose tissue surrounding internal organsposes greater health risks than subcutaneous fat, driving insulin resistance, cardiovascular disease, and metabolic dysfunction
First, this MR study examined the role of endogenous l-carnitine, which may not entirely correspond to exogenous carnitine supplementation
Too Much B12 and Acne You may have heard that vitamin B12 can cause acne, but that isnt the whole story